Did A Biotech CEO Reverse Her Own Aging Process?
/
According to BioViva and to interviews with its CEO, Elizabeth Parrish, Parrish received two therapies last year, one to protect against the loss of muscle mass, and one to lengthen her telomeres.
We are leaders in gene therapy innovation, developing advanced platforms designed to address severe genetic disorders and the underlying mechanisms of cellular aging.